Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen

The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subj...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 272; no. 2; pp. 758 - 765
Main Authors Woodward, D F, Nieves, A L, Spada, C S, Williams, L S, Tuckett, R P
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.1995
American Society for Pharmacology and Experimental Therapeutics
Subjects
Online AccessGet full text
ISSN0022-3565
1521-0103
DOI10.1016/S0022-3565(25)24478-0

Cover

Loading…
Abstract The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.
AbstractList The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.
The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.
The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.
Author Nieves, A L
Woodward, D F
Spada, C S
Tuckett, R P
Williams, L S
Author_xml – sequence: 1
  givenname: D F
  surname: Woodward
  fullname: Woodward, D F
– sequence: 2
  givenname: A L
  surname: Nieves
  fullname: Nieves, A L
– sequence: 3
  givenname: C S
  surname: Spada
  fullname: Spada, C S
– sequence: 4
  givenname: L S
  surname: Williams
  fullname: Williams, L S
– sequence: 5
  givenname: R P
  surname: Tuckett
  fullname: Tuckett, R P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7853191$$D View this record in MEDLINE/PubMed
BookMark eNqFUcFu1DAUtFBR2RY-oZJPCA4B27GdVBwQWtGCVIkDcLZenJfEkMTBdhYtB74db3fhwKWSJfv5zYyfZy7I2exnJOSKs1eccf36M2NCFKXS6oVQL4WUVV2wR2TDleAF46w8I5t_kCfkIsZvjHEpdXlOzqtalfyab8jv7QABbMLgfkFyfqa-o0AbHGDnfICRTr7FkXY-0CWDlgHz5binuPPfsaUu2YHGte8xpkiXERKOmIqs6HZZb-5pl8-ZDDHLLj7hnOgS1uCS73F-Sh53MEZ8dtovydeb91-2H4q7T7cft-_uCitVlYrrDrHUus5FjSVyAGikxVqyRnCUdQPQCZ3_pLSWQugGOwCmLWs1olJYXpLnR90l-B9rntVMLlocR5jRr9FUFZe8ZDIDr07AtZmwNUtwE4S9ORmW-2-OfRt8jAE7Y126Ny4FcKPhzBzSMffpmIP1RuR1SMewzFb_sf_qP8Q7jT-4fvjpApolxzaB9aPv90ZUwghTqToD3x6BmM3cOQwmWoezxTaTbDKtdw889QdlDrdH
CitedBy_id crossref_primary_10_1089_jop_1995_11_339
crossref_primary_10_1254_fpj_135_134
crossref_primary_10_1152_jn_00302_2011
crossref_primary_10_1152_jn_00938_2009
ContentType Journal Article
Copyright 1995 American Society for Pharmacology and Experimental Therapeutics
Copyright_xml – notice: 1995 American Society for Pharmacology and Experimental Therapeutics
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S0022-3565(25)24478-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
EndPage 765
ExternalDocumentID 7853191
10_1016_S0022_3565_25_24478_0
272_2_758
S0022356525244780
Genre Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
8WZ
A6W
AAJMC
AALRI
AAXUO
AAYOK
ABCQX
ABIVO
ABJNI
ABOCM
ABSQV
ACGFO
ACGFS
ACNCT
ADBBV
ADCOW
ADIYS
AENEX
AERNN
AFFNX
AFHIN
AFOSN
AGFXO
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HZ~
INIJC
KQ8
L7B
LSO
M41
MJL
MVM
O9-
OHT
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
TR2
UQL
VH1
W2D
W8F
WH7
WOQ
X7M
YBU
YHG
YQT
ZGI
ZXP
-
08R
0R
55
8RP
AALRV
ABFLS
ABSGY
ABZEH
ADBIT
ADKFC
AETEA
AIKQT
DL
FH7
GJ
HZ
X
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
ROL
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7X8
ID FETCH-LOGICAL-c457t-9fee36684578e3e1aaab4ce840b21e48baaf268535664226befaa06c0d6ee55e3
ISSN 0022-3565
IngestDate Fri Sep 05 07:48:24 EDT 2025
Wed Feb 19 01:21:51 EST 2025
Tue Jul 01 05:29:27 EDT 2025
Thu Apr 24 22:53:36 EDT 2025
Tue Jan 05 21:17:55 EST 2021
Sat Feb 01 16:08:06 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c457t-9fee36684578e3e1aaab4ce840b21e48baaf268535664226befaa06c0d6ee55e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 7853191
PQID 77141304
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_77141304
pubmed_primary_7853191
crossref_citationtrail_10_1016_S0022_3565_25_24478_0
crossref_primary_10_1016_S0022_3565_25_24478_0
highwire_pharmacology_272_2_758
elsevier_sciencedirect_doi_10_1016_S0022_3565_25_24478_0
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1995-02-01
PublicationDateYYYYMMDD 1995-02-01
PublicationDate_xml – month: 02
  year: 1995
  text: 1995-02-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationTitleAlternate J Pharmacol Exp Ther
PublicationYear 1995
Publisher Elsevier Inc
American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: Elsevier Inc
– name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014463
Score 1.6915617
Snippet The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model...
The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model...
SourceID proquest
pubmed
crossref
highwire
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 758
SubjectTerms Animals
Azepines - pharmacology
Female
Guinea Pigs
Histamine - pharmacology
Male
Platelet Activating Factor - analogs & derivatives
Platelet Activating Factor - pharmacology
Pruritus - chemically induced
Pyridinium Compounds - pharmacology
Triazoles - pharmacology
Title Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen
URI https://dx.doi.org/10.1016/S0022-3565(25)24478-0
http://jpet.aspetjournals.org/content/272/2/758.abstract
https://www.ncbi.nlm.nih.gov/pubmed/7853191
https://www.proquest.com/docview/77141304
Volume 272
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtx6BQxm5l2VUPa9lwndnyNY8jtJTRjUFTljch23JhS2PTOIX2Yb9951i2pGUt2QbBJCZyDvm-c3QknQshb_M0kn7hj1yWxrBASZPCzbzSg3cZTkhxwtq6BZ-_xMdn4adpNN3Y3LGilpZNNsxvbs0r-R9U4R7gilmy_4CsfijcgPeAL1wBYbj-FcZjXW35Rnt-ws68b_vctJGEWNC4rSAwm1078qr6IfHMIMfw9HM8YlpgP-kG5qDGxVQH3KjFEMu2Gw_2ohFOXTUYN1BfYr-76rxLIftu2Gb5trUpiK3qO_3WSMDK-TJt7Z0j51tVtS2kNQmdE2CqvDJhjmPn1DmthdlFOIEb_ZaR2cDoE8LtYJD-ZMoOU_26KuahLeZkVUw7MUG1nhjKzp4z3C3xAtvgs4RZzGaW-U5UGfk_phW1w7HQv7CHGb97DNauIRYotscAQ-qLlm9JivbNNxNtH1ywMv_qqEiQizMOMmySewxWPW0nkqmOWMKVe6CL34MUJiHtgxHtHYved2Jtk_udDHc5Xbom9t3rq9bPmjwkDzoS0Y-K7Y_Ihpw_JvsdUtcH1EblgO5TG8Mn5OeqStCqpIIalaCtSlBAn9oqQZVKUFQJ2qsEvUUlqFIJKhbwWKUS1KjEU3J2dDgZH7tdixE3D6OkcUellEEcp_AhlYH0hRBZmMs09DLmSzBYQpQshj8RVj2Yc57JUggvzr0iljKKZLBLtubVXD4jFFxpURYRG6VxECZZBCuxAuxj5otiFHtpMSBhjwHPu_r72AZmxk2gJYDIEUTO4IUgcm9AhnpYrQrQrBuQ9gDzzotW3jEHNq8b-qYnBLcNBdfMhG_0POEwD-HhopjLarngSeKjPxwOyK6ij5a24-DztQ9_QbaNfXhJtprLpXwFLn-TvW4V4ReREAOC
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+a+behavioral+model+for+peripherally+evoked+itch+suggests+platelet-activating+factor+as+a+potent+pruritogen&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=D+F+Woodward&rft.au=A+L+Nieves&rft.au=C+S+Spada&rft.au=L+S+Williams&rft.date=1995-02-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=272&rft.issue=2&rft.spage=758&rft_id=info:doi/10.1016%2Fs0022-3565%2825%2924478-0&rft_id=info%3Apmid%2F7853191&rft.externalDBID=n%2Fa&rft.externalDocID=272_2_758
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon